Saturn V Capital Management LP Portfolio

Auto-discovered 13F filer (Top-2000 by latest reported value).

SEC 13F CIK: 0001964437

What is a 13F filing? Who files one and when · What 13F filings can't tell you

SmallFocusedHealth TiltHigh Turnover how tags are computed

Q1 2026 · 21 positions · Total reported value $552.22M · Top-10 concentration 77.0% · Updated 2026-10-18

Last updated: 2026-10-18 · Source: SEC EDGAR Form 13F-HR

Turnover: 42.3% · 3 new · 6 cut · 2 exited

Active Share (vs S&P 500): 100.0% · vs QQQ: 100.0% — share of the book that differs from index weights (higher = more active) · ranking

Est. Qtr Return (Q2 2026 → Q3 2026): -11.5% · vs SPY -13.6% · Prev Value $697.47M — last quarter positions weighted by this quarter price moves · ranking

Est. QTD Return (Q3 2026 → newest close): -4.1% · vs SPY -6.3% · Latest Value $683.13M — latest reported positions valued at quarter-to-date price moves (still in progress) · ranking

In its Q1 2026 13F filing, Saturn V Capital Management LP disclosed 21 equity positions with a combined reported value of $552.22M. The filing implies a focused portfolio: its ten largest positions account for 77.0% of reported value. HoldingsHub classifies the profile as Small / Focused / Health Tilt / High Turnover.

The largest disclosed positions as of Q1 2026 were ALMS ($70.54M), AMLX ($60.46M), ABVX ($60.43M). By sector, the heaviest allocations are Health Care 100.0%. Versus the prior quarter, allocation shifted toward Health Care (+1.3pp) and away from Other (-1.3pp).

Versus the prior quarter, Saturn V Capital Management LP opened 3 new positions, trimmed 6 and fully exited 2, a turnover rate of 42.3% of positions. The portfolio's overlap with the prior quarter was 71% of names.

The largest new positions opened in Q1 2026 were CADL ($14.19M), ZURA ($4.40M), ANRO ($2.00M).

Of the 2 positions fully exited versus the prior quarter, the largest were OCUL ($18.27M), CNTA ($7.07M), IVA ($1.32M).

Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.

New Positions (Q1 2026)

  • CADL CANDEL THERAPEUTICS INC · $14.19M
  • ZURA ZURA BIO LTD · $4.40M
  • ANRO ALTO NEUROSCIENCE INC · $2.00M
  • MSLE SATELLOS BIOSCIENCE INC · $1.97M

Fully Exited (vs previous quarter)

  • OCUL OCULAR THERAPEUTIX INC · prev qtr: $18.27M
  • CNTA CENTESSA PHARMACEUTICALS PLC · prev qtr: $7.07M
  • IVA INVENTIVA SA · prev qtr: $1.32M

Insider Transactions (Form 4)

Latest Saturn V Capital Management LP buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.

No Form 4 filings for this fund yet — when its ownership in a stock crosses 10%, buys and sells are filed here within two business days.

Fund Profile

Saturn V Capital Management LP, based in Austin, TX, United States, files quarterly US equity holdings with the SEC on Form 13F. Its latest filing (Q2 2026) lists 23 positions worth $697.47M in total. HoldingsHub carries 12 quarters of its filings (Q3 2023–Q2 2026).

Firm Snapshot

  • Headquarters: AUSTIN, TX, United States
  • SEC registration: 801-128448 (status: Approved), registered 2023-07-27
  • Regulatory AUM (Form ADV): $793.21M as of 2026-08-04
  • Client mix (by RAUM): pension and profit-sharing plans 100%
  • Manages 3 private funds, of which 3 hedge funds

Portfolio Structure

  • 23 positions · $697.47M reported value (Q2 2026)
  • Top 10 holdings = 75.6% of reported value
  • Largest position: AMLX (AMYLYX PHARMACEUTICALS INC) at 11.9%
  • Average position size: $30.32M

Sector Tilt

  • Health Care 100.0%
  • (classified holdings cover 100% of value)

Quarterly Activity

  • Q2 2026: 3 new, 12 added, 6 reduced, 1 exited
  • 2 positions unchanged

Generated from the firm's public SEC Form 13F and ADV filings. It states what the firm has reported — not an evaluation of its strategy, and not investment advice.

Sector Allocation

Health Care 100.0%
Sort by: Value · CSV
# Shares Value Weight Allocation Change
1 3.20M $70.54M 12.77%
12.77%
Add
2 4.35M $60.46M 10.95%
10.95%
Reduce
3 542.70K $60.43M 10.94%
10.94%
Reduce
4 824.53K $47.91M 8.68%
8.68%
Add
5 1.20M $33.94M 6.15%
6.15%
Add
6 3.69M $33.65M 6.09%
6.09%
Add
7 281.90K $32.18M 5.83%
5.83%
Reduce
8 162.96K $30.81M 5.58%
5.58%
Reduce
9 449.93K $28.77M 5.21%
5.21%
Add
10 6.46M $26.67M 4.83%
4.83%
Add
11 626.63K $24.12M 4.37%
4.37%
Reduce
12 345.63K $18.94M 3.43%
3.43%
Add
13 966.61K $17.52M 3.17%
3.17%
Reduce
14 10.95M $14.23M 2.58%
2.58%
Add
15 2.90M $14.19M 2.57%
2.57%
New
16 516.76K $13.74M 2.49%
2.49%
Hold
17 4.17M $9.25M 1.68%
1.68%
Add
18 3.86M $6.49M 1.18%
1.18%
Hold
19 739.96K $4.40M 0.80%
0.80%
New
20 89.00K $2.00M 0.36%
0.36%
New
21 350.00K $1.97M 0.36%
0.36%
New

FAQ

What did Saturn V Capital Management LP buy in 2026-Q1?

In its 2026-Q1 13F filing, Saturn V Capital Management LP reported 21 equity positions worth $552.22M in aggregate; its largest disclosed positions were ALMS ($70.54M), AMLX ($60.46M), ABVX ($60.43M).

How large is Saturn V Capital Management LP's portfolio?

Saturn V Capital Management LP reported $552.22M of long equity holdings across 21 positions as of 2026-Q1. Top-10 holdings account for 77.0% of reported value.

What is Saturn V Capital Management LP's investment style?

HoldingsHub classifies the portfolio as Small / Focused / Health Tilt / High Turnover, computed from size, concentration, sector tilt and turnover.

Where does this data come from?

All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.

Embed this fund on your site

Copy the snippet below to show this fund's live top holdings on your blog or forum — free, auto-updating, links back to HoldingsHub.

<iframe src="https://holdingshub.top/funds/saturn-v-capital-management/widget" width="100%" height="520" frameborder="0" loading="lazy" title="HoldingsHub fund holdings"></iframe>

Preview the embeddable widget →